Schedule-dependent cytotoxic synergism of pemetrexed and erlotinib in human non-small cell lung cancer cells

Tianhong Li, Yi He Ling, I. David Goldman, Roman Perez-Soler

Research output: Contribution to journalArticlepeer-review

173 Scopus citations

Fingerprint Dive into the research topics of 'Schedule-dependent cytotoxic synergism of pemetrexed and erlotinib in human non-small cell lung cancer cells'. Together they form a unique fingerprint.

Medicine & Life Sciences